Yumanity Therapeutics Inc YMTX:NASDAQ

Last Price$1.78Cboe Previous Close - Real-Time Last Sale as of 4:00PM ET 6/24/22
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$1.75 (8)
Ask (Size)$1.77 (9)
Day Low / HighN/A - N/A
Volume223.0 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 06/24/2022

 

Yumanity Therapeutics Inc ( NASDAQ )

Price: $1.78
Change: +0.03 (1.71%)
Volume: 223.0 K
4:00PM ET 6/24/2022
 
 

Aptevo Therapeutics Inc ( NASDAQ )

Price: $3.88
Change: -0.13 (3.24%)
Volume: 51.2 K
4:00PM ET 6/24/2022
 
 

Forte Biosciences Inc ( NASDAQ )

Price: $1.30
Change: +0.07 (5.69%)
Volume: 1.8 M
4:00PM ET 6/24/2022
 
 

Stealth BioTherapeutics Corp ( NASDAQ )

Price: $0.28
Change: -0.01 (3.79%)
Volume: 212.1 K
4:00PM ET 6/24/2022
 
 

Navidea Biopharmaceuticals Inc ( NYSE MKT LLC )

Price: $0.65
Change: -0.09 (12.16%)
Volume: 135.3 K
8:00PM ET 6/24/2022
 

Read more news Recent News

Sector Update: Health Care Stocks Slip Amid Losses for Biotechs
4:06PM ET 6/06/2022 MT Newswires

Health care stocks were edging lower this afternoon, with the NYSE Health Care Index slipping 0.1% while the SPDR Health Care Select Sector ETF (XLV) was...

Sector Update: Health Care Stocks Edging Higher This Afternoon
1:34PM ET 6/06/2022 MT Newswires

Health care stocks were hanging on to small gains this afternoon, with the NYSE Health Care Index rising 0.2% while the SPDR Health Care Select Sector ETF...

Sector Update: Health Care
1:28PM ET 6/06/2022 MT Newswires

Health care stocks were hanging on to small gains this afternoon, with the NYSE Health Care Index rising 0.2% while the SPDR Health Care Select Sector ETF...

US Stocks Weakening in Midday Trading but Largely Staying on Positive Ground
1:24PM ET 6/06/2022 MT Newswires

US stocks were drifting away from their earlier gains Monday that followed an overnight advance for Chinese technology stocks amid signs of easing...

View all Commentary and Analysis

Biotech 101 Lecture 3: Looking At Major Biotech Catalysts
3:23PM ET 3/08/2022 Seeking Alpha

Wall Street Breakfast: What Moved Markets
7:59AM ET 11/13/2021 Seeking Alpha

Company Profile

Business DescriptionYumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. View company web site for more details
Address40 Guest Street
Boston, Massachusetts 02135
Phone+1.617.409.5300
Number of Employees48
Recent SEC Filing06/17/2022425
President, Chief Executive Officer & DirectorRichard Peters
Chief Financial Officer, Treasurer & Senior VPMichael D. Wyzga
Chief Medical OfficerBrigitte Robertson
Research HeadDaniel Tardiff

Company Highlights

Price Open$1.75
Previous Close$1.75
52 Week Range$0.95 - 13.90
Market Capitalization$19.3 M
Shares Outstanding10.8 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/11/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$3.95
Beta vs. S&P 500N/A
Revenue$2.8 M
Net Profit Margin-798.74%
Return on Equity-162.54%

Analyst Ratings as of 03/25/2022

Buy
1
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset